All In Biotech

Drug Trial Radar · NCT01873547

Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China

Different Efficacy Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Chronic Spinal Cord Injury in China

Last checked: Nov 20, 2026Latest source record: May 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Jun 2012

Primary completion

Oct 2014

Study completion Dec 2015

Sponsor

Lead sponsor
General Hospital of Chinese Armed Police ForcesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 10, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The morbidity of spinal cord injury (SCI) is increasing year by year significantly in China. The methods to treat SCI patients in sequela stage update are poor. Though traditional rehabilitation therapy is the routine method to treat SCI in sequela stage, aiming to improve the neurological disorders of these patients, such as sensory disturbance, dyskinesia, autologous adjustment of blood pressure, dysfunction of urination, defecation and perspiration , etc. What's a pity, the efficacy of the rehabilitation therapy is unsatisfactory. Rehabilitation Therapy can prevent the process of muscle atrophy and joint stiffness. However, it can not repair the damaged nerve function. Studies show that mesenchymal stem cell transplantation can remarkably improve the neurological function of SCI in animals without any severe side effect. In this study, 300 patients will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 SCI patients. They will also follow up 100 patients who only receive rehabilitation and another 100 patients who accept neither stem cell therapy nor rehabilitation. On this basis, the investigators can compare the efficacy of these two treatments.

Conditions

  • Spinal Cord Injury

Interventions

  • cell therapyBiological

    Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.

  • rehabilitationOther

    Patients only receive rehabilitation of limb function.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of changes in International Standards for Neurological Classification of Spinal Cord Injury according to American Spine Injury AssociationTime frame: Baseline, 6 and 12 months after recruitment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • General Hospital of Chinese People's Armed Police Forces

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.